Delivery Order SPE2DB20D1100-SPE2DB25FC9Y9
Award Date 6/20/25
Potential Completion Date 7/14/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, valued at $5,135.85 for the supply of Envarsus XR 4 mg tablets (100 count) to support federal medical procurement needs. This firm fixed price delivery order, which must be completed by July 11, 2025, was awarded through open competition with no set-aside designation. The award is issued under the company's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 8, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Envarsus XR 1 mg tablets (30-count) at a ceiling value of $1,553.40. The contract is a firm fixed-price delivery order with an ultimate completion date of May 30, 2025, and was competitively awarded without set-aside designation. This award represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 15, 2025, for ENVARSUS XR 4 mg tablets (100 count). The contract is valued at $1,841.40 under a firm fixed price arrangement with an ultimate completion date of August 5, 2025. This award represents a non-set-aside competitive procurement and serves as a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, valued at $1,288.86 for the supply of Envarsus XR 1 mg tablets (100-count units) to the Department of Defense Medical Supply Chain. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 11, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Envarsus XR 1 mg tablets (100-count units) with a ceiling value of $1,288.86. This competitively awarded, firm fixed-price delivery order is set to be completed by September 8, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single delivery order issued under a larger contract vehicle rather than a standalone...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Envarsus XR 1 mg tablets (100-count packaging). This firm fixed price delivery order, valued at $2,148.10, is scheduled for completion by August 18, 2025, and represents a non-set-aside, competitively awarded contract. The delivery order is a child contract issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,811.00 for Envarsus XR 1 mg tablets (100-count packages) with a completion deadline of December 17, 2025. This order was issued under firm fixed pricing with no set-aside designation. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive range of...
- AmerisourceBergen Drug Corp received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Envarsus XR 4 mg tablets in a quantity of 100 units, with a ceiling value of $1,711.95 and a firm fixed price structure. The contract is classified as a child award under a larger indefinite delivery contract vehicle and carries an ultimate completion date of August 21, 2025. The place of performance is located at AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,106.80 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. The order is for ENVARSUS XR 1 mg tablets in a 30-count supply. This is a firm fixed-price, non-set-aside contract with performance at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,811.00 to AmerisourceBergen Drug Corp for 100 tablets of Envarsus XR 1 mg on November 3, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for...